Literature DB >> 21540342

Genes and elite athletes: a roadmap for future research.

Nir Eynon1, Jonatan R Ruiz, José Oliveira, José Alberto Duarte, Ruth Birk, Alejandro Lucia.   

Abstract

There is compelling evidence that genetic factors influence several phenotype traits related to physical performance and training response as well as to elite athletic status. Previous case-control studies showed that ∼20 genetic variants seem to be associated with elite endurance athletic status. The present review aims to introduce novel methodological approaches in the field of sports genetics research, which can be applied in the near future to analyse the genotype profile associated with elite athletic status. These include genotype-phenotype association studies using gene expression analysis, analysis of post-transcriptional factors, particularly microRNAs, genome-wide scan linkage or genome-wide association studies, and novel algorithm approaches, such as 'genotype scores'. Several gaps in the current body of knowledge have been identified including, among others: small sample size of most athletic cohorts, lack of corroboration with replication cohorts of different ethnic backgrounds (particularly, made up of non-Caucasian athletes), the need of research accounting for the potential role of epigenetics in elite athletic performance, and also the need for future models that take into account the association between athletic status and complex gene-gene and gene-environment interactions. Some recommendations are provided to minimize research limitations in the field of sport genetics.

Mesh:

Substances:

Year:  2011        PMID: 21540342      PMCID: PMC3145924          DOI: 10.1113/jphysiol.2011.207035

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  48 in total

Review 1.  Genes and human elite athletic performance.

Authors:  Daniel G Macarthur; Kathryn N North
Journal:  Hum Genet       Date:  2005-02-22       Impact factor: 4.132

2.  The ACTN3 gene in elite Greek track and field athletes.

Authors:  I D Papadimitriou; C Papadopoulos; A Kouvatsi; C Triantaphyllidis
Journal:  Int J Sports Med       Date:  2007-09-18       Impact factor: 3.118

3.  A common haplotype and the Pro582Ser polymorphism of the hypoxia-inducible factor-1alpha (HIF1A) gene in elite endurance athletes.

Authors:  Frank Döring; Simone Onur; Alexandra Fischer; Marcel R Boulay; Louis Pérusse; Tuomo Rankinen; Rainer Rauramaa; Bernd Wolfarth; Claude Bouchard
Journal:  J Appl Physiol (1985)       Date:  2010-03-18

4.  Using molecular classification to predict gains in maximal aerobic capacity following endurance exercise training in humans.

Authors:  James A Timmons; Steen Knudsen; Tuomo Rankinen; Lauren G Koch; Mark Sarzynski; Thomas Jensen; Pernille Keller; Camilla Scheele; Niels B J Vollaard; Søren Nielsen; Thorbjörn Akerström; Ormond A MacDougald; Eva Jansson; Paul L Greenhaff; Mark A Tarnopolsky; Luc J C van Loon; Bente K Pedersen; Carl Johan Sundberg; Claes Wahlestedt; Steven L Britton; Claude Bouchard
Journal:  J Appl Physiol (1985)       Date:  2010-02-04

5.  PPARalpha gene variation and physical performance in Russian athletes.

Authors:  Ildus I Ahmetov; Irina A Mozhayskaya; David M Flavell; Irina V Astratenkova; Antonina I Komkova; Ekaterina V Lyubaeva; Pavel P Tarakin; Boris S Shenkman; Anastasia B Vdovina; Aleksei I Netreba; Daniil V Popov; Olga L Vinogradova; Hugh E Montgomery; Viktor A Rogozkin
Journal:  Eur J Appl Physiol       Date:  2006-02-28       Impact factor: 3.078

6.  Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint athletes.

Authors:  Anna-Kaisa Niemi; Kari Majamaa
Journal:  Eur J Hum Genet       Date:  2005-08       Impact factor: 4.246

7.  A transcriptional map of the impact of endurance exercise training on skeletal muscle phenotype.

Authors:  Pernille Keller; Niels B J Vollaard; Thomas Gustafsson; Iain J Gallagher; Carl Johan Sundberg; Tuomo Rankinen; Steven L Britton; Claude Bouchard; Lauren G Koch; James A Timmons
Journal:  J Appl Physiol (1985)       Date:  2010-10-07

8.  Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes.

Authors:  Iain J Gallagher; Camilla Scheele; Pernille Keller; Anders R Nielsen; Judit Remenyi; Christian P Fischer; Karim Roder; John Babraj; Claes Wahlestedt; Gyorgy Hutvagner; Bente K Pedersen; James A Timmons
Journal:  Genome Med       Date:  2010-02-01       Impact factor: 11.117

9.  Association of the ACTN3 R577X polymorphism with power athlete status in Russians.

Authors:  Anastasiya M Druzhevskaya; Ildus I Ahmetov; Irina V Astratenkova; Viktor A Rogozkin
Journal:  Eur J Appl Physiol       Date:  2008-05-10       Impact factor: 3.078

10.  ACTN3 R577X polymorphism and Israeli top-level athletes.

Authors:  N Eynon; J A Duarte; J Oliveira; M Sagiv; C Yamin; Y Meckel; M Sagiv; E Goldhammer
Journal:  Int J Sports Med       Date:  2009-06-18       Impact factor: 3.118

View more
  33 in total

Review 1.  Genetic inheritance effects on endurance and muscle strength: an update.

Authors:  Aldo M Costa; Luiza Breitenfeld; António J Silva; Ana Pereira; Mikel Izquierdo; Mário C Marques
Journal:  Sports Med       Date:  2012-06-01       Impact factor: 11.136

2.  ACTN3 genotype influences exercise-induced muscle damage during a marathon competition.

Authors:  Juan Del Coso; Marjorie Valero; Juan José Salinero; Beatriz Lara; Germán Díaz; César Gallo-Salazar; Diana Ruiz-Vicente; Francisco Areces; Carlos Puente; Juan Carlos Carril; Ramón Cacabelos
Journal:  Eur J Appl Physiol       Date:  2017-02-02       Impact factor: 3.078

3.  The GALNTL6 Gene rs558129 Polymorphism Is Associated With Power Performance.

Authors:  Julen Díaz Ramírez; Jesús Álvarez-Herms; Arkaitz Castañeda-Babarro; Jon Larruskain; Xabier Ramírez de la Piscina; Oleg V Borisov; Ekaterina A Semenova; Elena S Kostryukova; Nikolay A Kulemin; Oleg N Andryushchenko; Andrey K Larin; Liliya B Andryushchenko; Edward V Generozov; Ildus I Ahmetov; Adrian Odriozola
Journal:  J Strength Cond Res       Date:  2020-09-16       Impact factor: 3.775

Review 4.  More than a 'speed gene': ACTN3 R577X genotype, trainability, muscle damage, and the risk for injuries.

Authors:  Juan Del Coso; Danielle Hiam; Peter Houweling; Laura M Pérez; Nir Eynon; Alejandro Lucía
Journal:  Eur J Appl Physiol       Date:  2018-10-16       Impact factor: 3.078

5.  ACTN3 X-allele carriers had greater levels of muscle damage during a half-ironman.

Authors:  Juan Del Coso; Juan José Salinero; Beatriz Lara; César Gallo-Salazar; Francisco Areces; Carlos Puente; David Herrero
Journal:  Eur J Appl Physiol       Date:  2016-12-02       Impact factor: 3.078

Review 6.  Genes for elite power and sprint performance: ACTN3 leads the way.

Authors:  Nir Eynon; Erik D Hanson; Alejandro Lucia; Peter J Houweling; Fleur Garton; Kathryn N North; David J Bishop
Journal:  Sports Med       Date:  2013-09       Impact factor: 11.136

7.  Genetic test for the personalization of sport training.

Authors:  Zakira Naureen; Marco Perrone; Stefano Paolacci; Paolo Enrico Maltese; Kristjana Dhuli; Danjela Kurti; Astrit Dautaj; Roberta Miotto; Arianna Casadei; Bernard Fioretti; Tommaso Beccari; Francesco Romeo; Matteo Bertelli
Journal:  Acta Biomed       Date:  2020-11-09

Review 8.  Biomechanical factors influencing the performance of elite Alpine ski racers.

Authors:  Kim Hébert-Losier; Matej Supej; Hans-Christer Holmberg
Journal:  Sports Med       Date:  2014-04       Impact factor: 11.136

9.  Targeted genotype analyses of GWAS-derived lean body mass and handgrip strength-associated single-nucleotide polymorphisms in elite master athletes.

Authors:  Hannah Crossland; Jessica Piasecki; Daniel McCormick; Bethan E Phillips; Daniel J Wilkinson; Kenneth Smith; Jamie S McPhee; Mathew Piasecki; Philip J Atherton
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-06-24       Impact factor: 3.619

10.  Acyl coenzyme A synthetase long-chain 1 (ACSL1) gene polymorphism (rs6552828) and elite endurance athletic status: a replication study.

Authors:  Thomas Yvert; Zi-Hong He; Catalina Santiago; Yang Hu; Yan-Chun Li; Félix Gómez-Gallego; Carmen Fiuza-Luces; Zoraida Verde; Carlos A Muniesa; Jesús Oliván; Alfredo Santalla; Jonatan R Ruiz; Alejandro Lucia
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.